These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1690279)

  • 101. Comparison of double-antibody radioimmunoassay with Farr-technique radioimmunoassay and double-antibody enzyme immunoassay for alpha-fetoprotein.
    Kirkpatrick A; Wepsic HT; Nakamura RM
    Clin Chem; 1977 Jan; 23(1):50-9. PubMed ID: 64323
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Serum alpha 1-fetoprotein in liver disease.
    Kohn J; Müller U
    Lancet; 1970 Jan; 1(7638):142. PubMed ID: 4188748
    [No Abstract]   [Full Text] [Related]  

  • 103. Isolation of two forms of rat alpha-fetoprotein and comparison of their binding parameters with estradiol-17beta.
    Benassayag C; Vallette G; Cittanova N; Nunez E; Jayle MF
    Biochim Biophys Acta; 1975 Dec; 412(2):295-305. PubMed ID: 53073
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Serum alpha-1-fetoprotein in liver disease.
    Clark JV
    Lancet; 1970 Jan; 1(7637):88. PubMed ID: 4188659
    [No Abstract]   [Full Text] [Related]  

  • 105. Analysis of alpha-fetoprotein heterogeneity by an improved crossed immunoaffinoelectrophoretic technique.
    Albanese EA; Bachl BL; Mulcahy GM
    Anal Biochem; 1986 Nov; 158(2):302-6. PubMed ID: 2433958
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Two-step enzyme immunoassay for the determination of serum alpha-fetoprotein.
    Watanabe Y; Adachi T; Ito Y; Hirano K; Sugiura M
    Chem Pharm Bull (Tokyo); 1982 Dec; 30(12):4412-6. PubMed ID: 6188546
    [No Abstract]   [Full Text] [Related]  

  • 107. Alpha-fetoprotein in hepatocellular carcinoma with an abnormal electrophoretic alpha-1-fraction.
    Ganrot PO; Trell E
    Acta Med Scand; 1970 Oct; 188(4):303-5. PubMed ID: 5479661
    [No Abstract]   [Full Text] [Related]  

  • 108. Fifty years of discovery of alpha-fetoprotein as the first tumor marker.
    Nikulina D; Terentyev A; Galimzyanov K; Jurišić V
    Srp Arh Celok Lek; 2015; 143(1-2):100-4. PubMed ID: 25845261
    [TBL] [Abstract][Full Text] [Related]  

  • 109. [Crystallization of alpha-1-fetoprotein from plasma of a patient with primary liver cell carcinoma].
    Lehmann FG
    Klin Wochenschr; 1971 May; 49(10):609-11. PubMed ID: 4325408
    [No Abstract]   [Full Text] [Related]  

  • 110. An enzyme-labelled immunoassay for the measurement of alpha-fetoprotein.
    Burgett MW; Kwan S
    Ric Clin Lab; 1982; 12(1):299-306. PubMed ID: 6178146
    [No Abstract]   [Full Text] [Related]  

  • 111. Development of a highly sensitive and specific two-site enzyme immunoassay for parathyroid hormone (1-34): application to pharmacokinetic study on intranasal parathyroid hormone (1-34) in human.
    Kohno T; Murasugi N; Sakurai H; Watabe K; Nakamuta H; Koida M; Sugie Y; Nomura M; Yanagawa A
    J Clin Lab Anal; 1998; 12(5):268-75. PubMed ID: 9773956
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Ramucirumab and the controversial role of α-fetoprotein in hepatocellular carcinoma.
    Abou-Alfa GK
    Lancet Oncol; 2019 Feb; 20(2):177-179. PubMed ID: 30665868
    [No Abstract]   [Full Text] [Related]  

  • 113. Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of α-fetoprotein.
    Zhu AX; Finn RS; Galle PR; Llovet JM; Kudo M
    Lancet Oncol; 2019 Apr; 20(4):e191. PubMed ID: 30942178
    [No Abstract]   [Full Text] [Related]  

  • 114. Serum alpha-fetoprotein (AFP) in benign and malignant gastrointestinal diseases: evaluation of an immunoenzymatic assay.
    Alpert E
    Clin Chim Acta; 1975 Jan; 58(1):77-83. PubMed ID: 1122634
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Preparation by irradiation of a solid support for enzyme immunoassay.
    Kumakura M; Kaetsu I; Adachi S
    J Immunol Methods; 1984 Apr; 69(1):79-84. PubMed ID: 6201556
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Enzyme immunoassay of human alpha 1-fetoprotein.
    Bélanger L; Masseyeff R
    Methods Enzymol; 1982; 84():19-31. PubMed ID: 6178937
    [No Abstract]   [Full Text] [Related]  

  • 117. Letter to the Editor: Comment on Alpha-Fetoprotein Decrease From >1,000 to <500 ng/mL in Patients With Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.
    Akbulut S; Sahin TT; Yilmaz S
    Hepatology; 2020 Dec; 72(6):2242-2243. PubMed ID: 32583464
    [No Abstract]   [Full Text] [Related]  

  • 118. Immunoradioautographic study of alpha-fetoprotein in hepatoma cells.
    Suganuma T; Koura M; Isaka H; Tsukada Y; Murata F
    Histochemistry; 1980; 68(2):129-32. PubMed ID: 6158505
    [TBL] [Abstract][Full Text] [Related]  

  • 119. ASO Author Reflections: Fibrolamellar Hepatocellular Carcinoma and Alpha-Fetoprotein.
    McDonald JD; Hernandez JM
    Ann Surg Oncol; 2020 Jun; 27(6):1906-1907. PubMed ID: 32189170
    [No Abstract]   [Full Text] [Related]  

  • 120. Preparation of nanoparticles conjugated with enzyme and antibody and their use in heterogeneous enzyme immunoassays.
    Nilsson KG
    J Immunol Methods; 1989 Sep; 122(2):273-7. PubMed ID: 2477458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.